Envestnet Asset Management »

Apellis Pharmaceuticals shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.5M 156k 28.84
2024-06-30 $5.2M 135k 38.36
2024-03-31 $5.6M 95k 58.78
2023-09-30 $3.1M 81k 38.04
2023-06-30 $1.9M 21k 91.10
2023-03-31 $1.4M 21k 65.96
2022-09-30 $280k 4.1k 68.23

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
Deep Track Capital
State Street Corporation
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
FMR
Jennison Associates
Siren
Geode Capital Management

View all funds holding Apellis Pharmaceuticals